Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.

MLA

Crimini, Edoardo, et al. “Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.” The Oncologist, vol. 29, no. 2, Feb. 2024, pp. 159–65. EBSCOhost, https://doi.org/10.1093/oncolo/oyad229.

APA

Crimini, E., Tini, G., Tarantino, P., Ascione, L., Repetto, M., Beria, P., Ranghiero, A., Marra, A., Belli, C., Criscitiello, C., Esposito, A., Guerini Rocco, E., Barberis, M. C. P., Mazzarella, L., & Curigliano, G. (2024). Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience. The Oncologist, 29(2), 159–165. https://doi.org/10.1093/oncolo/oyad229

Chicago

Crimini, Edoardo, Giulia Tini, Paolo Tarantino, Liliana Ascione, Matteo Repetto, Paolo Beria, Alberto Ranghiero, et al. 2024. “Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.” The Oncologist 29 (2): 159–65. doi:10.1093/oncolo/oyad229.